中医药防治卵巢癌腹腔转移研究进展  

Research Progress of Traditional Chinese Medicine in the Prevention and Treatment of Abdominal Metastasis of Ovarian Cancer

作　　者：张芳梅 许尤琪[1] Zhang Fangmei;Xu Youqi(The Second Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210017,China)

机构地区：[1]南京中医药大学第二附属医院,江苏南京210017

出　　处：《亚太传统医药》2024年第12期218-222,共5页Asia-Pacific Traditional Medicine

摘　　要：卵巢癌被称为最致命的妇科恶性肿瘤,超过一半的病例确诊时已至晚期,其中有60%的癌细胞会在腹腔中发生扩散和转移,腹腔转移是导致卵巢癌患者反复复发,以及生存预后差的主要原因之一,现代医学多以控制局部发展为主要治疗目标,以化疗、放疗、靶向治疗、腹腔热灌注化疗、手术治疗等为主,但常因各种不良反应使得治疗被迫中断。中医药治疗卵巢癌腹腔转移优势独特,在改善临床症状、增效减毒、预防复发及转移等方面发挥着重要作用,综述中医药治疗卵巢癌腹腔转移的研究进展,为临床防治该病提供参考。Ovarian cancer is considered to be the most lethal gynecological malignant tumor,more than half of the cases are diagnosed at an advanced stage,of which 60%of cancer cells will spread and metastasize in the abdominal cavity,abdominal metastasis is one of the main reasons for the repeated recurrence and poor survival prognosis of ovarian cancer patients.Modern medicine mostly focuses on controlling local development as the main treatment goal.It mainly includes chemotherapy,radiotherapy,targeted therapy,intraperitoneal hyperthermic chemotherapy,surgical treatment,etc.,but the treatment is often forced to be interrupted due to various adverse reactions.Traditional Chinese medicine(TCM)can play a unique role in the treatment of abdominal metastasis of ovarian cancer and plays an important role in improving clinical symptoms,increasing efficiency reducing toxicity,and preventing recurrence and metastasis,which reviews the research progress of traditional Chinese medicine in the treatment of abdominal metastasis of ovarian cancer,to provide a reference for the clinical prevention and treatment of this disease.

关 键 词：卵巢癌 腹腔转移 中医药 研究进展 

分 类 号：R273[医药卫生—中西医结合]